IP Library Granted Patent US 9,630,981
Granted Patent B2
US 9,630,981 · App. 15/048,464 · Granted Apr 25, 2017

Processes for preparing functionalized F-POSS monomers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,630,981
App. No.
15/048,464
Granted
Apr 25, 2017
Kind
B2
Abstract

The present disclosure relates to compositions of matter comprising synthetic blends of at least two feedstocks that produce a distribution of fluorinated polyhedral oligomeric silsesquioxane compounds. The present disclosure also relates to methods of making such fluorinated polyhedral oligomeric silsesquioxane compounds from such synthetic blends. The present disclosure also relates to uses of such fluorinated polyhedral oligomeric silsesquioxane compounds.

Claims (33)

1. A process for preparing a derivatized F-POSS of the formula

comprising the step of contacting at least one F-POSS molecule of the formula

with a compound of the formula R 1 R 2 Si(OR 3 ) 2 ,

wherein

R is a long chain fluorinated alkyl;

R 1 and R 2 are each independently selected from the group consisting of C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic and 5-7 membered heteroaryl, wherein each hydrogen atom in R 1 and R 2 is independently optionally substituted by an R 4 ;

R 3 is a C 1 -C 8 alkoxy;

each R 4 is independently selected from the group consisting of halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 5 , —NR 5 R 6 , —OC(O)R 5 , —C(O)OR 5 , —C(O)R 5 , —OC(O)OR 5 , —C(O)NR 5 R 6 , —OC(O)NR 5 R 6 , —NR 5 C(O)R 6 , —NR 5 C(O)OR 6 and —NR 5 C(O)NR 5 R 6 , and when R 4 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic or 5-7 membered heteroaryl, each hydrogen atom in R 4 is independently optionally substituted by an R 7 ;

each R 5 and R 6 is independently selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, and 5-7 membered heteroaryl, wherein each hydrogen atom in R 5 and R 6 is independently optionally substituted by an R 7 ;

each R 7 is independently selected from the group consisting of halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 8 , —NR 8 R 9 , —OC(O)R 8 , —C(O)OR 8 , —C(O)R 8 , —OC(O)OR 8 , —C(O)NR 8 R 9 , —OC(O)NR 8 R 9 , —NR 8 C(O)R 9 , —NR 8 C(O)OR 9 and —NR 8 C(O)NR 8 R 9 , and when R 7 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic or 5-7 membered heteroaryl, each hydrogen atom in R 7 is independently optionally substituted by an R 10 ;

each R 8 and R 9 is independently selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic and 5-7 membered heteroaryl, wherein each hydrogen atom in R 8 and R 9 is independently optionally substituted by one or more R 10 ;

each R 10 is independently selected from the group consisting of hydrogen, halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 11 , —NR 11 R 12 , —OC(O)R 11 , —C(O)OR 11 , —C(O)R 11 , —OC(O)OR 11 , —C(O)NR 11 R 12 , —OC(O)NR 11 R 12 , —NR 11 C(O)R 12 , —NR 11 C(O)OR 12 and —NR 11 C(O)NR 11 R 12 , and when R 10 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, C 3 -C 8 cycloalkyl or 5-7 membered heteroaryl, each hydrogen in R 10 is independently optionally substituted by a moiety selected from the group consisting of halo, —NCO, —OR 11 , —NR 11 R 12 , —OC(O)R 11 , —C(O)OR 11 , —C(O)R 11 , —OC(O)OR 11 , —C(O)NR 11 R 12 , —OC(O)NR 11 R 12 , —NR 11 C(O)R 12 , —NR 11 C(O)OR 12 and —NR 11 C(O)NR 11 R 12 ; and

each R 11 and R 12 is independently selected from the group consisting of H, C 1 -C 8 alkyl, C 2 -C 8 alkenyl and C 2 -C 8 alkynyl, and when R 11 or R 12 are C 1 -C 8 alkyl, C 2 -C 8 alkenyl or C 2 -C 8 alkynyl, each hydrogen atom in R 11 and R 12 is independently optionally substituted by a fluorine atom,

in the presence of an aqueous base catalyst.

2. The process of claim 1 , wherein R 2 is C 1 -C 8 alkyl.

3. The process of claim 2 , wherein R 2 is methyl.

4. The process of claim 2 , wherein R 1 is C 1 -C 8 alkyl, wherein each hydrogen atom in R 1 is independently optionally substituted by an R 4 .

5. The process of claim 4 , wherein R 4 is —NCO, —OR 5 , —OC(O)R 5 , —C(O)OR 5 , —C(O)R 5 or —OC(O)OR 5 .

6. The process of claim 5 , wherein R 5 is C 1 -C 8 alkyl, wherein each hydrogen atom in R 5 is independently optionally substituted by an R 7 .

7. The process of claim 5 , wherein R 5 is C 2 -C 8 alkenyl, wherein each hydrogen atom in R 5 is independently optionally substituted by an R 7 .

8. The process of claim 7 , wherein R7 is C1-C8 alkyl, —NCO, —OR8, —NR8R9, —OC(O)R8, —C(O)OR8, —C(O)R8 or —OC(O)OR8.

9. The process of claim 8 , wherein R 8 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl or 5-7 membered heteroaryl, wherein each hydrogen atom in R 8 is independently optionally substituted by one or more R 10 .

10. The process of claim 9 , wherein R 10 is hydrogen or C 1 -C 8 alkyl, and when R 10 is C 1 -C 8 alkyl, R 10 is optionally substituted by a —OC(O)R 11 .

11. The process of claim 10 , wherein R 11 is H or C 1 -C 8 alkyl, and when R 11 is C 1 -C 8 alkyl, each hydrogen atom in R 11 is independently optionally substituted by a fluorine atom.

12. The process of claim 1 , wherein R 1 is n-propyl, optionally substituted by an R 4 .

13. The process of claim 10 , wherein R 4 is —OC(O)R 5 or —OC(O)OR 5 .

14. The process of claim 13 , wherein R 5 is —CH═CH 2 , optionally substituted by an R 7 .

15. The process of claim 14 , wherein R 7 is methyl.

16. The process of claim 1 , wherein the aqueous base catalyst is an aqueous ammonium salt.

17. The process of claim 16 , wherein the aqueous base catalyst is a tetraethylammonium salt.

18. The process of claim 17 , wherein the aqueous base catalyst is tetraethylammonium hydroxide.

19. The process of claim 1 , wherein the long chain fluorinated alkyl is 8/2, 6/2 or 4/2.

20. The process of claim 1 , wherein the at least one F-POSS molecule is selected from the group consisting of 8/2 F-POSS, 6/2 F-POSS and 4/2 F-POSS.

Assignments (3)
CORRECTIVE ASSIGNMENT TO REMOVE U.S. PATENT NOS. 10,525,504 AND U.S. PATENT APPLICATION NO. 14/268,757 PREVIOUSLY RECORDED AT REEL: 065406 FRAME: 0320. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 13, 2025
From: NBD NANOTECHNOLOGIES INC.
To: HENKEL AG & CO. KGAA
Reel/Frame 070510/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: NBD NANOTECHNOLOGIES INC.
To: HENKEL AG & CO. KGAA
Reel/Frame 065406/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2017
From: WARNER, JOHN C.; LOEBELENZ, JEAN R.; CHERUKU, SRINIVASA RAO; GERO, THOMAS WOODROW
To: NBD NANOTECHNOLOGIES, INC.
Reel/Frame 041599/0105 →